Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology congress (EAU) in London, UK. These trials investigate ...
Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
SurvivorNet on MSN
Diagnosing muscle-invasive bladder cancer: The initial work-up
When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...
Q. I have been seeing so much about the use of AI, but I want to know about risks. What are the risks that I should think about while navigating AI? A. Widespread access to artificial intelligence (AI ...
The risk artificial intelligence poses to students outweighs its benefits, concludes a Brookings Institution report released earlier this month. Yet the reality is that 85% of teachers and 86% of ...
Yesterday, we wrote about Clawdbot, a new AI personal assistant that's achieved viral status in Silicon Valley. Many AI agents have been criticized for over-promising and under-delivering, but early ...
As health systems enter 2026, chief medical information officers say the biggest IT risks are operational, financial and clinical — and many are converging at once. From ransomware threats to ...
The World Economic Forum is out with its 2026 Global Risks Report on Wednesday. The report captures a shifting landscape where geoeconomic confrontation leaps to the top spot on the list of business ...
Two new reports from United Educators (UE) highlight the top self-reported risks facing K-12 schools and colleges and universities. UE is an organization that helps educational institutions identify, ...
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis. Injected micronized ...
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary DNA methylation test for bladder cancer diagnosis. Injected micronized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results